Search Results - "Conley BA"

Indian clinical practice consensus guidelines for the management of locoregional laryngeal cancer – Update 2024.

Authors: Singhal, Manish Babu, K Govind Darling, HS et al.

Source: Cancer Research, Statistics & Treatment. 2025 Suppl 1, Vol. 8, pS16-S20. 5p.

The semantics and virtues of nondescriptivist normativism about mental disorder.

Authors: Fernández Castro, Víctor Pérez-Navarro, Eduardo

Source: Synthese; Jul2025, Vol. 206 Issue 1, p1-24, 24p

Neuroendocrine Carcinoma Presenting as Metastasis of Unknown Origin in Cervical Lymph Nodes: An Unwonted Case Report.

Authors: Kath, Anmol Handa, Prince Ganesan, Aparna et al.

Source: Indian Journal of Otolaryngology & Head & Neck Surgery (Springer Nature). Jun2025, Vol. 77 Issue 6, p2387-2390. 4p.

Integrating pan-immune-inflammation value into personalized survival prediction of nasopharyngeal carcinoma: a large-scale long-term retrospective study.

Authors: Li, Wen-Chao Ni, Wei-Qiong Zhang, Yu-Ling et al.

Source: BMC Cancer. 7/21/2025, Vol. 25 Issue 1, p1-11. 11p.

A novel serum protein biomarker for the late-stage diagnosis of nasopharyngeal carcinoma.

Authors: Pan, Yi-Xi Huang, Qi Xing, Shan et al.

Source: BMC Cancer. 4/1/2025, Vol. 25 Issue 1, p1-14. 14p.

Circulating tumour DNA as a promising biomarker for breast cancer diagnosis & treatment monitoring.

Authors: Ursekar, Riddhi Chaubal, Rohan Gandhi, Khushboo A. et al.

Source: Indian Journal of Medical Research. Mar2025, Vol. 161 Issue 3, p1-11. 11p.

The effect of low-intensity resistance exercise training on Serum tumor biomarkers and quality of life in women with breast cancer: A randomized controlled trial.

Authors: Kocamaz, Deniz Fidancioğlu, Nahide Ayhan Yilmaz, Ramazan Cihad et al.

Source: Cancer Biomarkers. 2025, Vol. 42 Issue 3, p1-8. 8p.

Diseases as social problems.

Authors: Saborido, Cristian Zamora-Bonilla, Jesús

Source: Synthese; Feb2024, Vol. 203 Issue 2, p1-16, 16p

The debate over proximate and ultimate causation in biology.

Authors: Shan, Yafeng¹, hmyfshan@ust.hk

Source: Synthese; Jan2025, Vol. 205 Issue 1, p1-29, 29p

A nanoencapsulated oral formulation of fenretinide promotes local and metastatic breast cancer dormancy in HER2/neu transgenic mice.

Authors: De Angelis, Maria Laura Francescangeli, Federica Aricò, Eleonora et al.

Source: Journal of Experimental & Clinical Cancer Research (17569966). 11/5/2024, p1-20. 20p.

Endoglin as a predictive biomarker for pemetrexed sensitivity in non-small-cell lung cancer: a cellular study.

Authors: Cheng CY Chuang WC Lin CP et al.

Source: Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2025 Jan 10; Vol. 95 (1), pp. 20. Date of Electronic Publication: 2025 Jan 10.

Publication Type: Journal Article

Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE

Characterization of ibrutinib's effects on the morphology, proliferation, phenotype, viability, and anti-inflammatory potential of adipose-derived mesenchymal stromal cells.

Authors: Silva-Carvalho, Amandda Évelin Bispo, Elizabete Cristina Iseke da Silva, Ingrid Gracielle Martins et al.

Source: Scientific Reports. 8/28/2024, Vol. 14 Issue 1, p1-11. 11p.

Phase II Study of Copanlisib in Patients With Tumors With PIK3CA Mutations: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1F.

Authors: Damodaran S Zhao F Deming DA et al.

Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2022 May 10; Vol. 40 (14), pp. 1552-1561. Date of Electronic Publication: 2022 Feb 08.

Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural; Adaptive Clinical Trial

Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

Phase II Study of Taselisib in PIK3CA-Mutated Solid Tumors Other Than Breast and Squamous Lung Cancer: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol I.

Authors: Krop IE Jegede OA Grilley-Olson JE et al.

Source: JCO precision oncology [JCO Precis Oncol] 2022 Feb; Vol. 6, pp. e2100424.

Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural

Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE

Inferring evolutionary trajectories from cross-sectional transcriptomic data to mirror lung adenocarcinoma progression.

Authors: Huang, Kexin Zhang, Yun Gong, Haoran et al.

Source: PLoS Computational Biology. 5/25/2023, Vol. 19 Issue 5, p1-22. 22p. 2 Diagrams, 5 Graphs.

Importance of Retinoic Acid Derivatives in Breast Cancer: A Literature Review.

Authors: J. P., MAGESH KIRUBAKARAN SHRIVASTAV, POOJA RAVICHANDRAN, SANGEETHA et al.

Source: Journal of Clinical & Diagnostic Research. Sep2025, Vol. 19 Issue 9, p1-6. 6p.

Employment of diverse in vitro systems for analyzing multiple aspects of disease, hereditary hemorrhagic telangiectasia (HHT).

Authors: Koh, Hyebin Kang, Woojoo Mao, Ying-Ying et al.

Source: Cell & Bioscience. 5/22/2024, Vol. 14 Issue 1, p1-18. 18p.

Detection of oral squamous cell carcinoma in clinical photographs using a vision transformer.

Authors: Flügge, Tabea Gaudin, Robert Sabatakakis, Antonis et al.

Source: Scientific Reports. 2/9/2023, Vol. 13 Issue 1, p1-7. 7p.

The Johns Hopkins Hope at Hopkins Clinic: supporting the comprehensive needs of individuals with metastatic breast cancer.

Authors: Stearns V Chen R Blackford AL et al.

Source: Breast cancer research and treatment [Breast Cancer Res Treat] 2025 Apr; Vol. 210 (3), pp. 551-562. Date of Electronic Publication: 2025 Jan 27.

Publication Type: Journal Article

Journal Info: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

Oncogene-driven lung cancer in the era of radiogenomics: current evidence and future developments.

Authors: Ryan J Kavanagh J Coleman N

Source: Discover oncology [Discov Oncol] 2025 Aug 20; Vol. 16 (1), pp. 1585. Date of Electronic Publication: 2025 Aug 20.

Publication Type: Journal Article; Review

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 101775142 Publication Model: Electronic Cited Medium: Internet ISSN: 2730-6011 (Electronic) Linking ISSN: 27306011 NLM ISO Abbreviation: Discov Oncol Subsets: PubMed not MEDLINE